MYLAN-SUMATRIPTAN
MYLAN PHARMACEUTICALS ULC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of MYLAN-SUMATRIPTAN in Canada?
Yes. MYLAN-SUMATRIPTAN 100MG has an active shortage reported to Health Canada (last updated September 2, 2026).
Why is MYLAN-SUMATRIPTAN not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will MYLAN-SUMATRIPTAN be available again?
The manufacturer's estimated resolution date is February 9, 2027. This is an estimate and can change; follow this page to get an email when the status changes.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
IMITREX TAB 100MG
GLAXO CANADA INC
IMITREX DF - TAB 100MG
GLAXOSMITHKLINE INC
TEVA-SUMATRIPTAN
TEVA CANADA LIMITED
RATIO-SUMATRIPTAN
RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED
RIVA-SUMATRIPTAN
LABORATOIRE RIVA INC.
Q-SUMATRIPTAN
QD PHARMACEUTICALS ULC
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
Estimated Resolution
2027-02-09
~4 months remaining (estimate)
This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.
DIN
02268922
Strength
100MG
Dosage Form
TABLET
Route
ORAL
Active Ingredient
SUMATRIPTAN
Tier
Unrated
Last Updated
2026-09-02
Reason for Shortage
Disruption of the manufacture of the drug.
Past Reports for This Drug
MYLAN-SUMATRIPTAN has 4 shortage/discontinuation reports on file — this is one of them.
Other Products from MYLAN PHARMACEUTICALS ULC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
500MG · DIN 02385473
333MG · DIN 02293269
40MG · DIN 02257963
10MG · DIN 02257955
DIN 02388138
DIN 02388146
50MG · DIN 02468549
2G · DIN 02407310
1G · DIN 02407302
12.5MG · DIN 02554631
100MG · DIN 02247244
25MG · DIN 02247243